Épisodes

  • Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting

    Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
    Oct 10 2025

    Dr Jeremy S Abramson from Massachusetts General Hospital in Boston, Dr Jennifer Crombie from Dana-Farber Cancer Institute also in Boston and Dr Laurie H Sehn from the BC Cancer Centre for Lymphoid Cancer in Vancouver, British Columbia, Canada, discuss recent updates on available and novel treatment strategies for follicular lymphoma. 

    CE information and select publications here.

    Voir plus Voir moins
    1 h
  • Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting

    Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
    Oct 2 2025

    Prof Meletios-Athanasios (Thanos) C Dimopoulos from Alexandra Hospital in Athens, Greece, Dr Hans Lee from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Joseph Mikhael from City of Hope Cancer Center in Phoenix, Arizona, and Dr Noopur Raje from Massachusetts General Hospital in Boston discuss recent updates on available and novel treatment strategies for relapsed/refractory multiple myeloma. 

    NCPD information and select publications here.

    Voir plus Voir moins
    58 min
  • Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy

    Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy
    Sep 19 2025

    Dr Beth Faiman from Case Comprehensive Cancer Center in Cleveland, Ohio, discusses nursing considerations with CAR T-cell therapy for patients with multiple myeloma.

    NCPD information and select publications here.

    Voir plus Voir moins
    53 min
  • Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason

    Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason
    Sep 6 2025

    Ms Charise Gleason from Emory Healthcare in Atlanta, Georgia, discusses the evolution of first-line therapy for patients with multiple myeloma.

    NCPD information and select publications here.

    Voir plus Voir moins
    54 min
  • Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier Leleu

    Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier Leleu
    Sep 5 2025

    Prof Xavier Leleu from Poitiers University Hospital in Poitiers, France, discusses nursing considerations in the treatment of newly diagnosed multiple myeloma.

    NCPD information and select publications here.

    Voir plus Voir moins
    53 min
  • Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care

    Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care
    Jul 30 2025

    Ms Kathleen D Burns from City of Hope Comprehensive Cancer Center in Duarte, California, discusses nursing considerations in the care of patients with prostate cancer.

    NCPD information and select publications here.

    Voir plus Voir moins
    44 min
  • Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches

    Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches
    Jul 18 2025

    Ms Jennifer Filipi from the Massachusetts General Hospital Cancer Center in Boston discusses nursing considerations for the treatment of ovarian cancer.

    NCPD information and select publications here.
    Voir plus Voir moins
    54 min
  • Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress

    Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress
    Jul 11 2025

    Dr Bita Fakhri, Dr Jeff Sharman, and nurse practitioners Dr Jacqueline Broadway-Duren and Ms Corinne Hoffman discuss the current treatment landscape for chronic lymphocytic leukemia and strategies to mitigate and manage treatment-emergent adverse events.

    NCPD information and select publications here.

    Voir plus Voir moins
    1 h et 30 min